Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial

Hamaluba M. et al, (2023), Wellcome Open Research, 8, 182 - 182

The global burden of Chikungunya fever among children: A systematic literature review and meta-analysis

Nyamwaya DK. et al, (2022), PLOS Global Public Health, 2, e0000914 - e0000914

Revealing the extent of the first wave of the COVID-19 pandemic in Kenya based on serological and PCR-test data

Ojal J. et al, (2022), Wellcome Open Research, 6, 127 - 127

Incidence of chikungunya virus infections among Kenyan children with neurological disease, 2014-2018: A cohort study.

Nyamwaya DK. et al, (2022), PLoS medicine, 19

Epidemiology of COVID-19 infections on routine polymerase chain reaction (PCR) and serology testing in Coastal Kenya.

Nyagwange J. et al, (2022), Wellcome open research, 7

Using cross-species vaccination approaches to counter emerging infectious diseases.

Warimwe GM. et al, (2021), Nature reviews. Immunology, 21, 815 - 822

COVID-19 transmission dynamics underlying epidemic waves in Kenya.

Brand SPC. et al, (2021), Science (New York, N.Y.), 374, 989 - 994

Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immunoglobulin G Antibody Seroprevalence Among Truck Drivers and Assistants in Kenya.

Kagucia EW. et al, (2021), Open forum infectious diseases, 8

Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.

Adetifa IMO. et al, (2021), Nature communications, 12

COVID-19 Transmission Dynamics Underlying Epidemic Waves in Kenya

Brand S. et al, (2021)

Assessing the level and determinants of COVID-19 Vaccine Confidence in Kenya

Orangi S. et al, (2021)

Incidence of chikungunya virus infections among Kenyan children with neurological disease: a prospective cohort study

Nyamwaya D. et al, (2021)

Revealing the extent of the first wave of the COVID-19 pandemic in Kenya based on serological and PCR-test data

Ojal J. et al, (2021), Wellcome Open Research, 6, 127 - 127

Seroprevalence of Antibodies to SARS-CoV-2 among Health Care Workers in Kenya.

Etyang AO. et al, (2021), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Improving SARS-CoV-2 cumulative incidence estimation through mixture modelling of antibody levels

Bottomley C. et al, (2021)

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Voysey M. et al, (2021), The Lancet, 397, 881 - 891

Endemic chikungunya fever in Kenyan children: a prospective cohort study.

Nyamwaya DK. et al, (2021), BMC infectious diseases, 21

Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial.

Juan-Giner A. et al, (2021), Lancet (London, England), 397, 119 - 127

Revealing the extent of the first wave of the COVID-19 pandemic in Kenya based on serological and PCR-test data.

Ojal J. et al, (2021), Wellcome open research, 6

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Voysey M. et al, (2021), The Lancet, 397, 99 - 111

Load More

Include forthcoming?